The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, received a $146,570 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports research to elucidate the cis-regulatory function of non-coding genetic variants associated with metabolic dysfunction-associated steatotic liver disease (MASLD). The research aims to identify regulatory variants that predict MASLD risk, investigate their impact on transcription factor binding, and assess their clinical utility in predicting disease onset and progression. The award period runs from January 1, 2025 to November 30, 2029. This grant supports NIDDK's mission to advance biomedical research and treatment of complex metabolic and liver diseases.
Generated 3/4/25, 7:24 AM